A single intravenous infusion of DMT, a fast-acting psychedelic compound found in the Amazonian brew ayahuasca, significantly ...

In A Nutshell Researchers used a light-based brain imaging technique in mice to watch, in real time, what happens in the ...

A massive backlash against LSD eventually culminated in a 1970 Congressional law declaring it a Schedule 1 drug, meaning it officially has "no accepted medical use" in the U.S.

What if relief from relentless worry did not mean another pill every morning, but one carefully supervised session that keeps helping for months. That is the promise and the big question behind a new ...

Over dinner recently a top agent told us they’d attended a party the evening before hosted by an A-list comedian’s company, and at the entrance were two waiters holding mysterious little spritz ...

Feb 2 (Reuters) - A clinical-trial provider sued psychedelic therapy developer Definium Therapeutics (DFTX.O), opens new tab on Monday in Delaware federal court, claiming it stole trade secrets ...

Forbes contributors publish independent expert analyses and insights. Dr. Cheryl Robinson covers areas of leadership, pivoting and careers. This voice experience is generated by AI. Learn more. This ...

San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a single dose of a lab-designed form of LSD can meaningfully calm chronic ...

"They said, 'We’re having a really good night.' I'm like, 'It could get better,' " the comedian recalled on 'The Tonight Show Starring Jimmy Fallon' on Jan. 7 Kevin Mazur/Getty Images A couple ...

Two major trials investigating the potential of the psychedelic drug LSD for reducing anxiety are set to conclude in 2026. Scientists are feeling positive after the drug’s success in an earlier-stage ...

Add Yahoo as a preferred source to see more of our stories on Google. Bill Gates once revealed that the same person who challenged his intellect as a teenager also pushed him into experimenting with ...

NORTH CHARLESTON, S.C. (WCIV) — A new clinical trial underway in the Lowcountry is drawing attention for its unconventional, and potentially groundbreaking, approach to treating anxiety. Researchers ...